Telesis Bio Inc.

telesisbio.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q3 FY2024 10-Q, filed Nov 7, 2024. Its latest SEC filing is a 15-12G from Jan 14, 2025.

The sections below describe the company as of the FY2023 annual report.

How Did They Make Money?

FY2023 revenue

Did Revenues Turn Into Profits?

No. It lost $47.7M in FY2023.

Operating income, FY2023

−169% of revenue

▲ 0% (Loss) vs FY2022 (−$46.5M, −169%)

Net income, FY2023

−173% of revenue

▼ −2% (Loss) vs FY2022 (−$48.5M, −177%)

Free cash flow, FY2023

−133% of revenue

▼ −15% (Loss) vs FY2022 (−$43.2M, −157%)

How Were They Changing?

Since the FY2023 annual report

Latest quarter: Q3 FY2024, the three months to Sep 30, 2024

Revenue: ▼ −62%; vs $4.1M in Q3 FY2023
Net income: ▼ −38% (Loss); vs −$10.6M in Q3 FY2023

Comments